静脉吸毒者动脉病变的手术与腔内治疗结局
该单中心回顾性研究分析2007至2019年因自我注射导致动脉并发症的11例吸毒患者共13处病变,手术占85%,腔内占15%。术后1个月并发症率和再干预率均为8%,保肢率和生存率100%。随访期内手术组无并发症或再干预,腔内治疗中期结局未知。
要点
- 自我注射所致动脉病变以假性动脉瘤为主,常伴感染。
- 手术修复早期并发症和再干预率低,保肢率与生存率均高。
- 腔内治疗的中期结局尚不明确,需谨慎选择。
核心结论
- 手术后并发症主要出现在术后早期,随访期并发症、再干预和手术相关死亡率低。
- 腔内治疗的中期结局仍未知。
研究设计与样本
- 共纳入11例患者(中位年龄36岁,范围27-47;男性73%),治疗13处动脉病变。
主要发现
- 13处病变中,假性动脉瘤10处(77%),假性动脉瘤合并动静脉瘘2处(15%),孤立性动静脉瘘1处(8%)。
- 病变部位:股总动脉5处(38%),股浅动脉4处(31%),股深动脉1处(8%),肱动脉2处(15%),锁骨下动脉1处(8%)。
- 13例中9例(69%)存在感染征象。
- 治疗方式:手术11例(85%),腔内2例(15%)。
- 术后1个月并发症率8%(1例股浅动脉结扎后下肢跛行),再干预率8%(1例间置移植物因反复自我注射破裂)。
临床怎么用
- 对于吸毒者自我注射导致的动脉病变,手术修复(如间置移植物、直接重建等)是主要治疗方式,早期并发症和再干预率低。
- 腔内治疗可用于特定病例(如非感染性假性动脉瘤或血流动力学不稳定的锁骨下动脉假性动脉瘤),但中期结局需进一步评估。
局限性
- 回顾性单中心研究,样本量小(11例患者,13处病变)。
- 腔内治疗组样本量极小(2例),随访时间短,中期结局未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study is to report an 18-year single-center experience in the surgical and endovascular treatment of arterial complications due to self-injection in drug abuser patients. METHODS: This retrospective single-center study was conducted analyzing a prospectively collected database including all endovascular or surgical procedures performed from January 2007 to December 2019 for any arterial complication due to self-injection in drug abuser patient. Collected data were patient demographic and comorbidity, site and type of arterial lesion (pseudoaneurysm [PA], arteriovenous fistula [AVF]), signs of systemic or local infection, and procedural data (endovascular/surgical treatment). End points were rate of postoperative complications, reintervention rate, limb salvage, and patients' early and long-term survival. RESULTS: In 11 patients (median age 36 years, range 27-47; male 73%), 13 arterial lesions were treated: 10 (77%) PA, 2 (15%) PA associated with AVF, and 1 (8%) isolated AVF. Arterial lesion involved common femoral artery in 5 (38%), superficial femoral artery in 4 (31%), profunda femoral artery in 1 (8%), brachial artery in 2 (15%), and subclavian artery in 1 (8%). Signs of infections were present in 9 of the 13 cases (69%). The treatment was surgical in 11 (85%) cases: 7 interposition graft (6 great saphenous vein, 1 arterial cryopreserved homograft), 2 direct reconstruction, 1 patch plasty with pericardium bovine patch, and 1 arterial ligation. Endovascular treatment was performed in 2 cases: 1 noninfected PA of the superficial femoral artery, and 1 55-mm PA of the postvertebral segment of the right subclavian artery with clinical sign of hemodynamic instability. At 1 month, postoperative complication rate was 8% (one lower limb claudication after superficial femoral artery ligation). Reintervention rate was 8% (interposition graft rupture for repeated self-injections). Limb salvage and patient survival were both 100%. Median follow-up was 5 years (range 1 month to 11.3 years); surgical group: median 8.2 years (range 2 months to 11.3 years); endovascular group: median 3.5 months (range 1-6). During follow-up, neither complications nor reinterventions occurred, and limb salvage was 100% for both groups. At 2, 4, and 6 years, overall estimated patient survival was 91%, 81%, and 81%, respectively, with no procedure-related death. CONCLUSIONS: After surgical or endovascular management of arterial lesions due to self-injection in drug abuser patients, complications occur mainly in the postoperative period. During follow-up, the surgical procedures have low rate of complications, reinterventions, and procedure-related mortality, whereas for the endovascular treatment the mid-term outcomes remain unknown.
引用
- Bianchini Massoni C, Mariani E, De Troia A, et al. Outcomes of Surgical and Endovascular Treatment for Arterial Lesions in Intravenous Drug Abusers. Ann Vasc Surg. 2020. PMID: 32561239. doi:10.1016/j.avsg.2020.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。